Lv3
278 积分 2025-07-10 加入
Exploring the next generation of antibody–drug conjugates
1个月前
已完结
HER2-targeted therapies beyond breast cancer — an update
1个月前
已完结
Exploring the next generation of antibody–drug conjugates
1个月前
已完结
Enhancing the bystander effect of antibody-drug conjugate by using a novel caspase-3 cleavable peptide linker to overcome tumor heterogeneity
2个月前
已完结
Trastuzumab Deruxtecan: Redefining Precision Oncology Across HER2-Driven Cancers
2个月前
已完结
Visualization of Intratumor Pharmacokinetics of [fam-] Trastuzumab Deruxtecan (DS-8201a) in HER2 Heterogeneous Model Using Phosphor-integrated Dots Imaging Analysis
2个月前
已完结
Bystander effect in antibody-drug conjugates: Navigating the fine line in tumor heterogeneity
2个月前
已完结
The Impact of PEGylation on Biological Therapies
2个月前
已完结
The role of hydrophilic linkers in next-generation antibody-drug conjugates
2个月前
已完结
Preparation and biological evaluation of antibody targeted metal-organic framework drug delivery system (TDDS) in Her2 receptor-positive cells
3个月前
已完结